Skip to main content

Agile Therapeutics Inc (NASDAQ: AGRX) Investor Securities Class Action Lawsuit 01/06/2017

  • If you purchased shares of Agile Therapeutics Inc (NASDAQ: AGRX), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

July 13, 2017 - The court granted the stipulation of dismissal filed by the parties. January 6, 2017 - An investor in shares of Agile Therapeutics Inc (NASDAQ: AGRX) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Agile Therapeutics Inc in connection with certain allegedly false and misleading statements m...



You must register (for free) or login to view the entire case.